{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:22:48Z","timestamp":1780514568342,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.yebeh.2023.109496","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T23:36:25Z","timestamp":1699054585000},"page":"109496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population"],"prefix":"10.1016","volume":"149","author":[{"given":"Alexis","family":"Biehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maralena","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0612-2255","authenticated-orcid":false,"given":"Robert J.","family":"Kotloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Kopacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-7134","authenticated-orcid":false,"given":"Barry E.","family":"Gidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109496_b0005","unstructured":"Lamictal. Full prescribing information (last revised October 2020). GlaxoSmithKline, Research Triangle Park, NC 27709, USA. Available from n.d."},{"key":"10.1016\/j.yebeh.2023.109496_b0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2023.109496_b0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2012.07.029","article-title":"Health and health behavior differences: U.S. Military, veteran, and civilian men","volume":"43","author":"Hoerster","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.yebeh.2023.109496_b0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamacardio.2021.0227","article-title":"Association of posttraumatic stress disorder and incident ischemic heart disease in women veterans","volume":"6","author":"Ebrahimi","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.yebeh.2023.109496_b0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jagp.2014.12.003","article-title":"PTSD and risk of incident cardiovascular disease in aging veterans","volume":"24","author":"Beristianos","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.yebeh.2023.109496_b0030","first-page":"589","article-title":"Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses. Int","volume":"40","author":"Campos","year":"2018","journal-title":"J Clin Pharm"},{"key":"10.1016\/j.yebeh.2023.109496_b0035","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2023.109496_b0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/B978-0-12-804766-8.00025-X","article-title":"Epilepsy and aging","volume":"167","author":"Kotloski","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.yebeh.2023.109496_b0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/epi.16068","article-title":"The medical treatment of epilepsy in the elderly: A systematic review and meta-analysis","volume":"60","author":"Lezaic","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109496_b0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archneurol.2010.49","article-title":"Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy","volume":"67","author":"Arif","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2023.109496_b0055","doi-asserted-by":"crossref","unstructured":"Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol 2021;11:20451253211045870. https:\/\/doi.org\/10.1177\/20451253211045870.","DOI":"10.1177\/20451253211045870"},{"key":"10.1016\/j.yebeh.2023.109496_b0060","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/heart.84.6.625","article-title":"Prevalences of ECG findings in large population based samples of men and women","volume":"84","author":"De Bacquer","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.yebeh.2023.109496_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pcad.2008.06.003","article-title":"Epidemiology of sudden cardiac death: clinical and research implications","volume":"51","author":"Chugh","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.yebeh.2023.109496_b0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrcardio.2010.3","article-title":"Sudden cardiac death: epidemiology and risk factors","volume":"7","author":"Adabag","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.yebeh.2023.109496_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/epi4.12475","article-title":"FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE\/AES Task Force","volume":"6","author":"French","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2023.109496_b0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0000000000200189","article-title":"Cardiac safety of lamotrigine: still awaiting a verdict","volume":"98","author":"Auerbach","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109496_b0085","first-page":"3353684","article-title":"Sinus Bradycardia in an adolescent taking lamotrigine","volume":"2022","author":"Davis","year":"2022","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.yebeh.2023.109496_b0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-017-0441-0","article-title":"Sodium Channel blockers in the treatment of epilepsy","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2023.109496_b0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eplepsyres.2004.10.002","article-title":"Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents","volume":"63","author":"Danielsson","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109496_b0100","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/cts.13311","article-title":"Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications","volume":"15","author":"Ingleby-Talecki","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.yebeh.2023.109496_b0105","doi-asserted-by":"crossref","first-page":"e1748","DOI":"10.1212\/WNL.0000000000200164","article-title":"Sudden death and cardiac arrythmia with lamotrigine: A rapid systematic review","volume":"98","author":"Bunschoten","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109496_b0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2125.2008.03250.x","article-title":"Lamotrigine does not prolong QTc in a thorough QT\/QTc study in healthy subjects","volume":"66","author":"Dixon","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2023.109496_b0115","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109496_b0120","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/epi.17339","article-title":"Cardiac morbidity and mortality associated with the use of lamotrigine","volume":"63","author":"Christensen","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109496_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/epi.17696","article-title":"Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FAERS analysis","author":"Aboukaoud","year":"2023","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023004158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023004158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:54:49Z","timestamp":1761504889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023004158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":25,"alternative-id":["S1525505023004158"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109496","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lamotrigine use and potential for adverse cardiac effects: A retrospective evaluation in a Veteran population","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109496"}}